Similarly, given the extensive research on liver-targeted nano-based drug delivery systems, encapsulating SIRT1 modulators into specially designed liver-targeted functionalized nanocarriers represents a promising strategy for the treatment of liver diseases. The gene discussed is SIRT1; the disease is liver disorder.